Australia markets closed

PMV Pharmaceuticals, Inc. (PMVP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.7800-0.2800 (-5.53%)
At close: 04:00PM EDT
4.8000 +0.02 (+0.42%)
After hours: 07:26PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
49,130
51,988
36,493
23,933
20,759
Selling general and administrative
25,220
25,052
21,800
11,009
5,878
Total operating expenses
74,350
77,040
58,293
34,942
26,637
Operating income or loss
-74,350
-77,040
-58,293
-34,942
-26,637
Total other income/expenses net
74
87
21
-143
-8
Income before tax
-72,340
-73,326
-57,823
-34,434
-25,344
Income tax expense
-9
-9
23
6
8
Income from continuing operations
-72,331
-73,317
-57,846
-34,440
-25,352
Net income
-72,331
-73,317
-57,846
-34,440
-25,352
Net income available to common shareholders
-72,331
-73,317
-57,846
-34,440
-25,352
Basic EPS
-
-
-1.28
-2.40
-0.81
Diluted EPS
-
-
-1.28
-2.40
-0.81
Basic average shares
-
-
45,138
14,364
31,223
Diluted average shares
-
-
45,138
14,364
31,223
EBITDA
-
-76,725
-57,986
-34,624
-26,249